Literature DB >> 109501

Antibody responses of burned patients immunized with a polyvalent Pseudomonas vaccine.

R J Jones.   

Abstract

In two controlled clinical trials of a polyvalent pseudomonas vaccine, vaccinated burned patients showed higher antibody titres to the 16 antigens in the vaccine and higher titres of a passively transferable protective antibody than was found in unvaccinated burned patients.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 109501      PMCID： PMC2130075          DOI： 10.1017/s0022172400053973

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN： 0022-1724


  8 in total

1.  HOSPITAL INFECTION WITH PSEUDOMONAS PYOCYANEA: AN INVESTIGATION BY A COMBINED PYOCINE AND SEROLOGICAL TYPING METHOD.

Authors:  A H WAHBA
Journal:  Br Med J       Date:  1965-01-09

2.  STAPHYLOCOCCAL ANTIBODIES IN BURNED PATIENTS.

Authors:  R J JONES; E J LOWBURY
Journal:  Br J Exp Pathol       Date:  1963-12

3.  Passive protective properties of serum fractions from mice inoculated with an anti-pseudomonas vaccine.

Authors:  R J Jones; M Hall; C R Ricketts
Journal:  Immunology       Date:  1972-12       Impact factor: 7.397

4.  Protective properties and haemagglutinins in serum from humans and in serum from mice injected with a new polyvalent Pseudomonas vaccine.

Authors:  R J Jones; E A Roe
Journal:  Br J Exp Pathol       Date:  1975-02

5.  A new Pseudomonas vaccine: preliminary trial on human volunteers.

Authors:  R J Jones; E A Roe; E J Lowbury; J J Miler; J F Spilsbury
Journal:  J Hyg (Lond)       Date:  1976-06

6.  A new polyvalent Pseudomonas vaccine.

Authors:  J M Miler; J F Spilsbury; R J Jones; E A Roe; E J Lowbury
Journal:  J Med Microbiol       Date:  1977-02       Impact factor: 2.472

7.  Gram-negative bacilli in burns.

Authors:  B Davis; H A Lilly; E J Lowbury
Journal:  J Clin Pathol       Date:  1969-11       Impact factor: 3.411

8.  Low mortality in burned patients in a Pseudomonas vaccine trial.

Authors:  R J Jones; E A Roe; J L Gupta
Journal:  Lancet       Date:  1978-08-19       Impact factor: 79.321
  8 in total
  3 in total

1.  Immunochemical and biochemical analysis of the polyvalent Pseudomonas aeruginosa vaccine PEV.

Authors:  S MacIntyre; T McVeigh; P Owen
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

2.  Smooth lipopolysaccharide is the major protective antigen for mice in the surface extract from IATS serotype 6 contributing to the polyvalent Pseudomonas aeruginosa vaccine PEV.

Authors:  S MacIntyre; R Lucken; P Owen
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

3.  Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans.

Authors:  S J Cryz; E Fürer; A S Cross; A Wegmann; R Germanier; J C Sadoff
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.